Improving Access to Addiction and Mental Health Care for Veterans
This study is looking at ways to improve how many Veterans with alcohol use disorder, depression, opioid use disorder, or PTSD receive effective treatments. It compares two approaches: Participatory System Dynamics (PSD), which involves staff running simulations to find better ways to provide care, and Audit and Feedback (AF), where staff review data to improve care. The study aims to see if PSD helps more patients get the care they need. To join, your clinic must be a VA division or community-based outpatient clinic (CBOC) that is below the overall VA quality median for certain measures related to addiction and mental health care. Success will be measured by the proportion of patients who start and continue evidence-based treatments and the completion of treatment templates. The current status of this study is unclear.
- Study design
- This interventional study plans to enroll 720 participants. It compares two different strategies for improving healthcare delivery.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures outcomes over a 24-month total observation period, looking at changes over 12-month periods before and after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health Care
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lindsey E Zimmerman, PhD · PRINCIPAL_INVESTIGATOR · National Center for PTSD, Dissemination & Training Division
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of patients diagnosed with alcohol use disorder, depression, opioid use disorder, or PTSD who meet evidence-based psychotherapy and pharmacotherapy initiation and course measures divided by total number of patients with these diagnosesPre-/Post- 12-month period average of evidence-based practice reach (24 months total observation)
Initiation of an evidence-based practice is indicated by an evidence-based psychotherapy template or evidence-based pharmacotherapy prescription after intake. Adequate course is based on receiving an adequate number of evidence-based psychotherapy sessions to be a "completer" (typically 8 sessions) or enough refills for a guideline-recommended adequate trial of each medication (varies by medication). Data is gathered based on electronic health record data from the VA Corporate Data Warehouse (CDW).
- Proportion of completed evidence-based practice templates during sessions with a relevant CPT codePre-/Post- 12-month period average of evidence-based practice reach (24 months total observation)
We will study 5 evidence-based psychotherapies: 3 for depression (Cognitive Behavior Therapy (CBT-D), Acceptance and Commitment Therapy (ACT), and Interpersonal Psychotherapy (IPT)) and 2 for PTSD (Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT)). Data is gathered based on electronic health record data from the Corporate Data Warehouse (CDW).
- Proportion of combination of prescriptions placed with the VA pharmacy and sessions with a relevant CPT codePre-/Post- 12-month period average of evidence-based practice reach (24 months total observation)
We will study 8 evidence-based pharmacotherapies: 2 for depression (84 and 180 days therapeutic continuity at new antidepressant start), 2 for Opioid Use Disorder (OUD) (methadone and buprenorphine), and 4 for Alcohol Use Disorder (AUD) (Acamprosate, Disulfiram, Naltrexone, and Topiramate). Data is gathered based on electronic health record data from the Corporate Data Warehouse (CDW).